000 01389 a2200421 4500
005 20250512034138.0
264 0 _c19861202
008 198612s 0 0 eng d
022 _a0306-5251
024 7 _a10.1111/j.1365-2125.1986.tb02886.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPacifici, G M
245 0 0 _aValpromide inhibits human epoxide hydrolase.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_cSep 1986
300 _a269-74 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnticonvulsants
_xpharmacology
650 0 4 _aBenzopyrenes
650 0 4 _aEpoxide Hydrolases
_xantagonists & inhibitors
650 0 4 _aEpoxy Compounds
650 0 4 _aFemale
650 0 4 _aFetus
_xenzymology
650 0 4 _aHumans
650 0 4 _aIntestines
_xenzymology
650 0 4 _aKidney
_xenzymology
650 0 4 _aLung
_xenzymology
650 0 4 _aMale
650 0 4 _aMicrosomes, Liver
_xenzymology
650 0 4 _aMiddle Aged
650 0 4 _aValproic Acid
_xanalogs & derivatives
700 1 _aFranchi, M
700 1 _aBencini, C
700 1 _aRane, A
773 0 _tBritish journal of clinical pharmacology
_gvol. 22
_gno. 3
_gp. 269-74
856 4 0 _uhttps://doi.org/10.1111/j.1365-2125.1986.tb02886.x
_zAvailable from publisher's website
999 _c3100372
_d3100372